Trial Profile
The CHRONOS study: Can the sleep-deprivation induced antidepressive effect in patients with major depression be sustained by correction of diurnal rhythms, long term light treatment and duloxetine treatment?
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 11 Aug 2009 Actual patient number (75) added as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Mar 2009 as reported by ClinicalTrials.gov.